FDA Inspection
Seatex LLCSeatex LLC – FDA Inspection, Oct 20, 2023
Record Details
This FDA Inspection record concerns Seatex LLC, with an inspection on October 20, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e848e3af-2f81-4022-aef8-93e8d52386c0
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1220824
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
12- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.137(a)Expiration date lacking
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)Complete test data included in records
Showing 10 of 12 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Seatex LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 20, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2012 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Seatex LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.